The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Background & Aims: Endoscopic retrograde cholangiography (ERCP) has been considered the gold standard for the diagnosis and follow‐up of primary sclerosing cholangitis, but it has been replaced by less invasive magnetic resonance imaging and cholangiopancreatography (MRI‐MRCP). However, the role of these two techniques in the evaluation of disease activity and severity needs to be elucidated. Methods: Patients with primary sclerosing cholangitis (n: 48, male 31, median age: 35.7; 28.0‐44.2) who underwent ERCP and MRI‐MRCP within ±3 months for diagnosis or follow‐up, were reviewed. ERCP and MRI‐MRCP images were scored using the modified Amsterdam score. Serum and biliary cytology markers of disease activity and severity were related to the imaging findings. Agreement on the assessment of the ERCP/MRCP score was calculated by kappa‐statistics. Spearman′s ρ was calculated when appropriate. Results: The agreement between ERCP and MRCP in scoring bile duct changes for disease severity was only moderate (weighted kappa: 0.437; 95% CI: 0.211‐0.644 for intra‐ and 0.512; 95% CI: 0.303‐0.720 for extra‐hepatic bile ducts). ERCP and MRCP intra‐hepatic scores were associated to the surrogate marker alkaline phosphatase (P = .02 for both). A weak correlation between MRCP score for extra‐hepatic bile ducts and liver transplantation/death was found (Spearman's ρ = .362, 95% CI: 0.080‐0.590, P = .022). A weak correlation between intra‐ (Spearman′s ρ = .322, 95% CI: 0.048‐0.551, P = .022) and extra‐hepatic (Spearman`s ρ = .319, 95% CI: 0.045‐0.549, P = .025) peribiliary enhancement on contrast‐enhanced MRI and severity of biliary cytologic classification was found. Conclusions: The overall agreement between ERCP and MRI‐MRCP in assessing disease severity was moderate for intra‐ and extra‐hepatic bile ducts. MRI‐MRCP seems to have a minor role as surrogate marker of disease activity and progression in PSC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Hepatic and extrahepatic malignancies in primary sclerosing cholangitis
Bergquist, A., Ekbom, A., Olsson, R., Kornfeldt, D., Lööf, L., Danielsson, Å., Hultcrantz, R., Lindgren, S., Prytz, H., Sandberg-Gertzén, H., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00288-4 · Cited by 717
Charatcharoenwitthaya, P., Enders, F. B., Halling, K. C., & Lindor, K. D. (2008) · Hepatology · doi:10.1002/hep.22441 · Cited by 393
Dave, M., Elmunzer, B. J., Dwamena, B. A., & Higgins, P. D. R. (2010) · Radiology · doi:10.1148/radiol.10091953 · Cited by 265
Aabakken, L., Karlsen, T., Albert, J., Arvanitakis, M., Chazouilleres, O., Dumonceau, J.-M., Färkkilä, M., Fickert, P., Hirschfield, G., Laghi, A., et al. (2017) · Endoscopy · doi:10.1055/s-0043-107029 · Cited by 255
Self-citationTrikudanathan, G., Navaneethan, U., Njei, B., Vargo, J. J., & Parsi, M. A. (2014) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2013.09.015 · Cited by 203
Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis
Boberg, K. M., Jebsen, P., Clausen, O. P., Foss, A., Aabakken, L., & Schrumpf, E. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.010 · Cited by 159
Ruiz, A., Lemoinne, S., Carrat, F., Corpechot, C., Chazouillères, O., & Arrivé, L. (2014) · Hepatology · doi:10.1002/hep.26620 · Cited by 144
Sinakos, E., Saenger, A. K., Keach, J., Kim, W. R., & Lindor, K. D. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.02.007 · Cited by 142
Lewis, J. T., Talwalkar, J. A., Rosen, C. B., Smyrk, T. C., & Abraham, S. C. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181bc96f9 · Cited by 122
Cited by
Berzigotti, A., Tsochatzis, E., Boursier, J., Castera, L., Cazzagon, N., Friedrich-Rust, M., Petta, S., & Thiele, M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.05.025 · Cited by 1,925
“A study comparing cholangiographic findings obtained by ERCP and MRI reported a weak correlation between cholangiographic findings and major outcomes [239].”
ResultAASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Bowlus, C. L., Arrivé, L., Bergquist, A., Deneau, M., Forman, L., Ilyas, S. I., Lunsford, K. E., Martinez, M., Sapisochin, G., Shroff, R., et al. (2023) · Hepatology · doi:10.1002/hep.32771 · Cited by 428
Barner-Rasmussen, N., Pukkala, E., Jussila, A., & Färkkilä, M. (2020) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2019.1707277 · Cited by 80
“MRIMRCP seems to have a minor role as a surrogate marker of disease activity and progression in PSC [32].”
BackgroundSelf-citationLemoinne, S., Cazzagon, N., El Mouhadi, S., Trivedi, P. J., Dohan, A., Kemgang, A., Ben Belkacem, K., Housset, C., Chretien, Y., Corpechot, C., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.03.013 · Cited by 78
Rupp, C., Hippchen, T., Bruckner, T., Klöters-Plachky, P., Schaible, A., Koschny, R., Stiehl, A., Gotthardt, D. N., & Sauer, P. (2019) · Gut · doi:10.1136/gutjnl-2018-316801 · Cited by 73
Metadata
- Authors
- Tenca, A., Mustonen, H., Lind, K., Lantto, E., Kolho, K., Boyd, S., Arola, J., Jokelainen, K., & Färkkilä, M.
- Venue
- Liver International
- Publisher
- Wiley
- Published
- 2018-07-18
- Volume
- 38
- Issue
- 12
- Pages
- 2329-2339
- ISSN
- 0106-9543 (ISSN-L)
- 1478-3223
- 1478-3231
- OpenAlex
- W2808124587
- Cited by
- 37
- References
- 15
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis. https://app.cochat.ai/papers/10.1111/liv.13899
- The paper
- Tenca, A., Mustonen, H., Lind, K., Lantto, E., Kolho, K., Boyd, S., Arola, J., Jokelainen, K., & Färkkilä, M. (2018). The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis. Liver International. https://doi.org/10.1111/liv.13899
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.